Biology Reference
In-Depth Information
Challa, M., Malladi, S., Pellock, B. J., Dresnek, D., Varadarajan, S., Yin, Y. W., White, K., and
Bratton, S. B. (2007). Drosophila Omi, a mitochondrial-localized IAP antagonist and proapopto-
tic serine protease. EMBO J. 26, 3144-3156.
Chaudhuri, A., Bowling, K., Funderburk, C., Lawal, H., Inamdar, A., Wang, Z., and O'Donnell, J. M.
(2007). Interaction of genetic and environmental factors in a Drosophila parkinsonism model.
J. Neurosci. 27, 2457-2467.
Chen, H., and Chan, D. C. (2009). Mitochondrial dynamics—Fusion, fission, movement, and
mitophagy—In neurodegenerative diseases. Hum. Mol. Genet. 18, R169-R176.
Chen, L., and Feany, M. B. (2005). Alpha-synuclein phosphorylation controls neurotoxicity and
inclusion formation in a Drosophila model of Parkinson disease. Nat. Neurosci. 8, 657-663.
Chen, H., McCaffery, J. M., and Chan, D. C. (2007). Mitochondrial fusion protects against
neurodegeneration in the cerebellum.
Cell 130, 548-562.
Chen, L., Periquet, M., Wang, X., Negro, A., McLean, P. J., Hyman, B. T., and Feany, M. B. (2009).
Tyrosine and serine phosphorylation of alpha-synuclein have opposing effects on neurotoxicity
and soluble oligomer formation.
J. Clin. Invest. 119, 3257-3265.
Clark, I. E., Dodson, M. W., Jiang, C., Cao, J. H., Huh, J. R., Seol, J. H., Yoo, S. J., Hay, B. A., and
Guo, M. (2006). Drosophila pink1 is required for mitochondrial function and interacts genetically
with parkin.
Nature 441, 1162-1166.
Conway, K. A., Harper, J. D., and Lansbury, P. T. (1998). Accelerated in vitro fibril formation by a
mutant alpha-synuclein linked to early-onset Parkinson disease.
Nat. Med. 4, 1318-1320.
Dagda, R. K., Cherra, S. J., 3rd, Kulich, S. M., Tandon, A., Park, D., and Chu, C. T. (2009). Loss of
PINK1 function promotes mitophagy through effects on oxidative stress and mitochondrial
fission.
J. Biol. Chem. 284, 13843-13855.
Deng, H., Dodson, M. W., Huang, H., and Guo, M. (2008). The Parkinson's disease genes pink1 and
parkin promote mitochondrial fission and/or inhibit fusion in Drosophila.
Proc. Natl. Acad. Sci.
USA 105, 14503-14508.
Dietzl, G., Chen, D., Schnorrer, F., Su, K. C., Barinova, Y., Fellner, M., Gasser, B., Kinsey, K.,
Oppel, S., Scheiblauer, S., et al. (2007). A genome-wide transgenic RNAi library for conditional
gene inactivation in Drosophila. Nature 448, 151-156.
Drobysheva, D., Ameel, K., Welch, B., Ellison, E., Chaichana, K., Hoang, B., Sharma, S.,
Neckameyer, W., Srinakevitch, I., Murphy, K. J., et al. (2008). An optimized method for
histological detection of dopaminergic neurons in Drosophila melanogaster.
J. Histochem. Cyto-
chem. 56, 1049-1063.
Du, G., Liu, X., Chen, X., Song, M., Yan, Y., Jiao, R., and Wang, C. C. (2010). Drosophila histone
deacetylase 6 protects dopaminergic neurons against {alpha}-synuclein toxicity by promoting
inclusion formation. Mol. Biol. Cell 21, 2128-2137.
Eriksen, J. L., Przedborski, S., and Petrucelli, L. (2005). Gene dosage and pathogenesis of Parkinson's
disease.
Trends Mol. Med. 11, 91-96.
Exner, N., Treske, B., Paquet, D., Holmstrom, K., Schiesling, C., Gispert, S., Carballo-Carbajal, I.,
Berg, D., Hoepken, H. H., Gasser, T.,
. (2007). Loss-of-function of human PINK1 results in
mitochondrial pathology and can be rescued by parkin.
et al
J. Neurosci. 27, 12413-12418.
Faust, K., Gehrke, S., Yang, Y., Yang, L., Beal, M. F., and Lu, B. (2009). Neuroprotective effects of
compounds with antioxidant and anti-inflammatory properties in a Drosophila model of Parkin-
son's disease.
BMC Neurosci. 10, 109.
Feany, M. B., and Bender, W. W. (2000). A
Drosophila
model of Parkinson's disease.
Nature 404,
394-398.
Fernandez-Funez, P., Nino-Rosales, M. L., de Gouyon, B., She, W. C., Luchak, J. M., Martinez, P.,
Turiegano, E., Benito, J., Capovilla, M., Skinner, P. J.,
et al
. (2000). Identification of genes that
modify ataxin-1-induced neurodegeneration.
Nature 408, 101-106.
